PRF Technologies Issues Letter to Shareholders Highlighting Strengthened Financial Position and Building Momentum Across Its Biotechnology and AI-Driven Energy Platforms Life Science Investing
Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer Life Science Investing
Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer Life Science Investing
PharmaTher Launches Personaliz3D Peptides to Advance Personalized Peptide Care Following Positive FDA Advisory Committee Recommendations Life Science Investing
Arrowhead Pharmaceuticals Completes Enrollment in Global Phase 3 YOSEMITE Study of Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia Life Science Investing
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline Life Science Investing
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline Biotech Investing
Radoff-JEC Group Urges Seer Stockholders to Vote "FOR" All Three of its Independent, Highly Qualified Nominees on the WHITE Proxy Card TODAY Life Science Investing
